Eupraxia Pharmaceuticals
(NASDAQ) EPRX
Eupraxia Pharmaceuticals Financials at a Glance
Market Cap
$421.91M
Revenue (TTM)
$0.00
Net Income (TTM)
$47.35M
EPS (TTM)
$-0.99
P/E Ratio
-6.92
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.86
Volume
63,682.5
Open
$7.17
Price
$6.86
Volume
63,682.5
Open
$7.17
Previous Close
$6.86
Daily Range
$6.79 - $7.22
52-Week Range
$2.96 - $9.32
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.86
Volume
63,682.5
Open
$7.17
Previous Close
$6.86
Daily Range
$6.79 - $7.22
52-Week Range
$2.96 - $9.32
EPRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eupraxia Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
James A. Helliwell, MD
Website
www.eupraxiapharma.comHeadquarters
Victoria, BC V8R 5G4, CA
EPRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-67%
Return on Capital
-51%
Return on Assets
-48%
Earnings Yield
-14.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$421.91M
Shares Outstanding
61.50M
Volume
63.68K
Short Interest
0.00%
Avg. Volume
216.89K
Financials (TTM)
Gross Profit
$241.68K
Operating Income
$39.07M
EBITDA
$38.83M
Operating Cash Flow
$29.03M
Capital Expenditure
$598.77K
Free Cash Flow
$29.63M
Cash & ST Invst.
$80.35M
Total Debt
$153.95K
Eupraxia Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$73.86K
N/A
Gross Margin
0.00%
N/A
Market Cap
$421.91M
N/A
Market Cap/Employee
$12.79M
N/A
Employees
33
N/A
Net Income
$16.95M
-57.0%
EBITDA
$16.32M
-51.8%
Quarterly Fundamentals
Net Cash
$80.20M
+142.8%
Accounts Receivable
$672.45K
+193.8%
Inventory
$0.00
N/A
Long Term Debt
$75.71K
N/A
Short Term Debt
$185.90K
+158.7%
Return on Assets
-47.95%
N/A
Return on Invested Capital
-51.36%
N/A
Free Cash Flow
$10.07M
-67.5%
Operating Cash Flow
$9.88M
-65.4%